Exposure-Response Analyses for Belzutifan to Inform Dosing Considerations and Labeling.
Marathe DD, Jauslin PM, Jan Kleijn H, De Miranda Silva C, Chain A, Abraham AK, Kauh EA, Liu Y, Perini RF, Alwis DP, Jain L.
Marathe DD, et al. Among authors: chain a.
J Clin Pharmacol. 2024 Oct;64(10):1246-1258. doi: 10.1002/jcph.2459. Epub 2024 May 16.
J Clin Pharmacol. 2024.
PMID: 38752556
Clinical Trial.